Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Catalys Pacific, LLC (CIK 2011385) reported $230.7M across 2 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: MLYS ($214.1M, 92.81%), PHAT ($16.6M, 7.19%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | MLYS | Mineralys Therapeutics, Inc. | $214.1M | 92.81% | 7.9M | Hold |
| 2 | PHAT | Phathom Pharmaceuticals, Inc. | $16.6M | 7.19% | 1.5M | Added |
Source: SEC Form 13F filings · as of 2026-03-31